Reversible valproic acid-induced dementia: a case report.
Reversible valproic acid-induced dementia was documented in a 21-year-old man with epilepsy who had a 3-year history of insidious progressive decline in global cognitive abilities documented by serial neuropsychological studies. Repeat neuropsychological testing 7 weeks after discontinuation of the drug revealed dramatic improvement in IQ, memory, naming, and other tasks commensurate with clinical recovery in his intellectual capacity. Possible pathophysiological mechanisms which may have been operative in this case include: a direct central nervous system (CNS) toxic effect of valproic acid; a paradoxical epileptogenic effect secondary to the drug; and an indirect CNS toxic effect mediated through valproic acid-induced hyperammonemia.
D000328:Adult; D000641:Ammonia / Q000097:blood; D003704:Dementia / Q000139:chemically induced*; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008297:Male; D011581:Psychological Tests; D014635:Valproic Acid / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use
D014635:Valproic Acid; D000641:Ammonia